Jan 29-31, 2025
Amsterdam, Netherlands
Amsterdam, Netherlands
Ncardia’s Charles Leach will be attending #ILBDC next week in Amsterdam, and is looking forward to connecting with leading neurodegenerative scientists. Fill out the form below to schedule a time to meet with him and discuss how our innovative neurological products and services can help propel your critical discovery programs.
ABOUT US
Predict future safety and efficacy more efficiently
For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC). Our iPSC drug discovery platforms have been successfully leveraged by large biopharmas, up-and-coming drug discovery firms and multinational research consortia to advance therapeutic candidates for cardiovascular, neurological and other disease areas.
Meet with Charles at ILBDC 2025!